Editorial
Welcome to Journal of Angiogenesis Research
-
* Corresponding author: Mark Slevin m.a.slevin@mmu.ac.uk
1 Section of Vascular Biology, School of Biology, Chemistry and Health Science, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK
2 Department of Clinical Biomedicine, ICCC, St Pau Hospital, Barcelona, Spain
3 Department of Vascular biology, Microbiology, Tumor and Cell Biology, Nobels väg 16, Karolinska Institute, 171 77, Stockholm, Sweden
4 Department of Reproductive Sciences, Columbia University Medical Center, Columbia, New York, USA
Journal of Angiogenesis Research 2009, 1:1 doi:10.1186/2040-2384-1-1
Published: 21 September 2009Abstract
Angiogenesis is the growth of new blood vessels and is a key process which occurs during both physiological and pathological disease processes. Knowledge of the mechanisms through which this process is initiated and maintained will have a significant impact on the treatment of these diseases. Pathological angiogenesis occurs in major diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality.